To determine whether CD4+ T cells participate in the recruitment of other lymphocyte subsets to the lungs, we examined pulmonary immune responses in C57BL/6 mice treated in vivo with the MAb GK1.5, either intact (which depletes CD4+ cells) or as F(ab')2 fragments (which block CD4 molecules). After intratracheal challenge with sheep erythrocytes, antigenprimed mice treated with intact GK1.5 had marked decreases in lymphocytes and macrophages in bronchoalveolar lavage fluid and minimal parenchymal inflammation, compared to primed mice treated with an isotype-matched irrelevant antibody or with no antibody. At 7 d after challenge, flow cytometric analysis showed that numbers ofThy 1.2+ and B220+ cells, but not of CD8+ cells, were markedly decreased in lavage fluid of CD4-depleted mice. Similar suppression of the pulmonary immune response to intratracheal challenge was found in primed mice injected repeatedly with F(ab')2 fragments of GK1.5, which did not deplete CD4+ T cells, and in athymic mice. These findings indicate that, in response to a single intratracheal antigen challenge, recruitment to the lungs of leukocytes other than CD8+ T cells depends largely on CD4+ T cells, possibly because of signals requiring T cell activation via interactions with antigen-presenting cells. (J. Clin. Invest.
Introduction
Helper T cells appear to be crucial both for defense ofthe lung against specific pathogens and in the development ofimmunologic lung diseases. Helper T cells are required for the differentiation of antigen-activated precursor lymphocytes (both B cells and cytotoxic T cells) into immune effectors. Moreover, helper T cells secrete cytokines that activate macrophages, endothelial cells, and other pulmonary cells to express adhesion molecules, to elaborate chemotactic and proinflammatory cytokines, and to present antigens, all ofwhich are pivotal steps in the development ofprotective immune responses (1) . Helper T cells are the predominant lymphocytes in the lungs of patients with sarcoidosis and are prominent in idiopathic pulmonary fibrosis (2, 3) . Considerable evidence, both from clinical and experimental research, suggests that helper T cells are essential components of the deranged immune responses that appear to underlie these important lung diseases (4, 5) .
Helper T lymphocytes can be identified by surface expression of the CD4 molecule (in mice also termed L3T4), a transmembrane glycoprotein of roughly 55-kD relative mass, expressed on thymocytes and helper T cells of all mammals (6) . Monoclonal antibodies (MAbs) against CD4 block T cell activation in vitro and when used in vivo have profound immunosuppressive effects (7, 8) . Systemic therapy with MAbs against CD4 has recently been used in the treatment of rheumatoid arthritis (9, 10); whether such therapy would be useful in immunologic lung diseases or would impair development of protective immune responses is unknown.
The generation of immune responses in the lung parenchyma is believed to depend heavily on recruitment oflymphocytes, in particular from regional lymph nodes (1 1). Lymphocyte recruitment is a multistep process involving adhesion to and transmigration of endothelial cells, penetration of the vascular basement membrane, directed migration through extracellular matrix, and selective retention (12) . Each ofthese steps in cellular accumulation has been extensively studied in vitro; however, the significance of findings from these studies to the pathogenesis ofimmunologic lung diseases remains undefined. It is critical for an understanding of pulmonary host defense that events within the lung parenchyma be studied directly, because immunologic diseases within the lung parenchyma are poorly reflected by changes in the organized systemic lymphoid tissue (a process termed compartmentalization [ 13] ).
This laboratory is performing an ongoing series of in vivo studies to determine the cellular and molecular mechanisms underlying pulmonary immune responses. We have used sheep red blood cells as a particulate, T cell-dependent antigen which mimics a variety of organic antigens that could be inhaled or aspirated into the lower respiratory tract. These studies have demonstrated that intratracheal antigen challenge of previously primed mice with sheep red blood cells results in immune activation of alveolar macrophages (as evidenced by increased expression of class II major histocompatibility antigens and ability to present antigen in vitro and in vivo); recruitment of large numbers of lymphocytes and monocytes, and smaller numbers of neutrophils to the lung parenchyma; and in situ maturation of recruited B cells to specific antigen-secreting cells (14) (15) (16) (17) (18) (19) . These changes require intratracheal challenge with specific antigen, and cannot be elicited by intratracheal inoculation ofa nonspecific irritant (such as hydrochloric acid) or even of an unrelated erythrocyte antigen, suggesting a requirement for local antigen-driven signals. During this pulmonary immune response, CD4-positive (+) T cells appear in bronchoalveolar lavage fluid earlier and in greater numbers than do other lymphocyte subsets (18) . Based on this observa-tion, and the known capability of CD4+ T cells to secrete the chemotactic cytokine interleukin 2 (IL2), we hypothesized that, in this experimental model, CD4+ T cells participate in the recruitment of other lymphocyte subsets to the lungs. To explore the role of CD4+ T cells in vivo, we studied the consequences of systemic treatment of mice with GKl.5, a rat MAb directed against murine CD4. Two complementary experimental designs were used: systemic depletion of CD4+ T cells by injection of intact GKl.5 and surface blockade of the CD4 molecule by F(ab')2 fragments of GKl.5. We found that, with both designs, recruitment of inflammatory cells to the alveolar spaces and lung parenchyma in response to intratracheal antigen challenge was profoundly inhibited.
Methods
Animals. Most experiments were performed using specific pathogenfree female C57BL/6 mice obtained at 8-10 wk of age from Jackson Laboratories, Bar Harbor, ME, or Simonsen Laboratories, Gilroy, CA. Athymic male C57BL/6 X BALB/c Fl (B6/CBy Fl) nu/nu mice and their normal littermates, obtained at 5 wk ofage from Jackson Laboratories, were used in selected experiments. Athymic BALB/c nu/nu mice, obtained at 5-6 wk of age from Simonsen Laboratories, were used to produce large quantities of monoclonal antibodies. (17) . Thus, it is likely that sheep red blood cells function solely as an antigen in this model system.
Experimental protocols. To establish the duration of CD4+ ablation induced by intact GK1.5, in initial experiments primed mice were injected intraperitoneally with 2 mg of antibody on day -4 or -5 and again with 1 mg on day -2. Mice were then bled on various days (without intratracheal challenge or additional antibody injections). Lymphocytes were purified from peripheral blood by centrifugation through Lympholyte-M (Cedarlane Laboratories, Homby, Ontario) and their phenotypes were determined by flow cytometry.
In subsequent studies with intact antibodies, primed mice were injected with either GKI.5 or the irrelevant control antibody (SFR8-B6) following this same protocol. An additional group of mice, referred to subsequently as the untreated group, did not receive antibody. On day 0, all mice next received an intratracheal antigen challenge (5 X 108 sheep red blood cells in 0.05 ml of saline) as previously described (14) . This technique causes the majority of the antigen to be deposited and retained in the alveolar spaces (26) and results in a reproducible pulmonary immune response (16) (17) (18) (19) . This antigen dose, which is higher than that used in most of our previously reported studies, was chosen because it induces more vigorous cellular recruitment to the lungs (16) .
At various times after challenge, mice were deeply anesthetized with pentobarbital and killed by exsanguination. We have previously shown that the peak response to the standard treatment was at 3-4 d after IT immunization and that the response declines thereafter (19) . Mice next underwent a 12-ml total lung lavage with PBS in 1-ml aliquots as previously described (17) . After recovery of the last aliquot of lavage fluid, the lungs were inflated with 10% formalin in PBS (vol/vol) at a constant pressure (19) (18) and stained by hematoxylin and eosin.
We counted 200 cells per slide.
Procedureforflow cytometry. We identified lymphocyte subpopulations in bronchoalveolar lavages, peripheral blood, and spleen by staining cells with MAbs and analyzing them by flow cytometry. Lavages of individual mice were analyzed for the untreated group and for the group treated with the irrelevant antibody, but for the group treated Cells were suspended at 2-4 X I07 ml1' in minimal essential medium (Cell Culture Facility, University ofCalifornia, San Francisco) containing 0.1% sodium azide (Mallinckrodt Chemicals, Inc., St. Louis, MO) and 25 mM Hepes (Sigma Chemical Co.). Aliquots of 25 ul were stained with 50 y1 of MAb at previously defined optimal dilutions in 96-well, round-bottomed plates (Linbro, Hamden, CT).
Flow cytometry was performed using a FACS 440 (Becton-Dickinson Immunocytometry Systems, Mountain View, CA), equipped with an argon laser (Coherent 90-6, emission wavelength of 488 nm, operated at 200 mW), a rhodamine-G dye laser (Coherent 90-4 + 599, emission wavelength of 610 nm, operated at 300 mW), and a four-decade logarithmic amplifier. Data were stored in list mode on a VAX 11380 computer (Digital Equipment Corp., Maynard MA) and were analyzed using ELECTRIC DESK software (Becton-Dickinson). For each lavage sample we analyzed a minimum of20,000 cells, excluding erythrocytes, dead cells, and debris by forward angle scatter gating before collecting data (27) . In each experiment, these exclusions and the adequacy of compensation between the photomultiplier tubes for the two fluorochromes were confirmed by staining with FITC-conjugated antibody and biotinylated antibody against the common leukocyte antigen, T200 (murine CD45).
We identified lymphocytes among bronchoalveolar lavage cells by comparing their light scatter characteristics to those ofsplenic or peripheral blood lymphocytes analyzed in the same experiment (18) . Flow cytometry data are expressed as absolute number of lymphocytes per mouse of each phenotypic subpopulation in lavage samples. We determined these numbers by the product ofthe total cell count (by hemocytometer), the percentage of lymphocytes (by differential cell counts of slides prepared by the gravity filtration method), and the percentage of each lymphocyte subpopulation (by flow cytometry).
The CD4 molecule has been reported on macrophages of humans and rats (28), but has not been found on resident peritoneal macrophages of mice (29) (30) (31) . To our knowledge, alveolar macrophages of mice have not been examined for expression of CD4. Therefore, to exclude the possibility that effects on inflammatory cell influx could be due in part to an effect on alveolar macrophages, in separate experiments we examined bronchoalveolar lavages ofmice that had not been injected with GK1.5 for CD4 staining by flow cytometry, using strepta- Figure 1 . Kinetics of depletion of CD4+ T cells by intact GK1.5. Primed mice were injected intraperitoneally with intact GK1.5 (2 mg on day -2 and 1 mg on day 0). Individual mice were then bled two to three times each over 2 wk and the percentage of CD4+ T cells in peripheral blood was determined by flow cytometry. Data are mean±SEM; (-) mice treated with GK1.5 (n = 3-6 mice assayed individually); (o) normal mice (n = 14 mice assayed individually).
vidin-allophycocyanin (Becton-Dickinson) to minimize the effect of macrophage autofluorescence (32) .
Preparation and grading ofhistologic specimens. After inflation of the lungs with formalin, the entire thoracic contents were dissected and were fixed by immersion in 10% formalin in PBS for 18-24 h. Parasagittal sections through the lungs were then cut, embedded in paraffin, and sectioned at 5 um in thickness. The slides, each consisting of the entire lungs from a single mouse, were stained with hematoxylin and eosin and in some cases with the Verhoeff-van Gieson stain for elastin. Slides were coded and were graded in a blinded fashion by one of the authors (Dr. Warnock), a pathologist specializing in pulmonary diseases, using a reproducible scoring system developed for use in this model (19) . Inflammatory changes in five categories were graded separately on each slide: (a) the alveolar parenchyma away from major vessels; (b) the perivenular region; (c) the bronchoarterial region; (d) venous endothelial changes; and (e) arterial endothelial changes. Grading was based on the most severely inflamed section on each slide. The specific grading criteria are summarized in Table II lymphocytes. This absence of staining confirms that CD4+ T cells had been ablated; their CD4 molecules had not simply been masked by GK1.5. Effect oftreatment with intact GKI.5 on recruitment ofinflammatory cells into the lungs. As anticipated from previous work with this model (16, 18) , intratracheal challenge ofsystemically primed mice caused an increase in the number ofleukocytes in bronchoalveolar ravages, due to increases in all leukocyte subtypes (Fig. 2) . Similar results were seen in mice treated with the irrelevant antibody. In contrast, treatment with GK1.5 markedly inhibited recruitment of total bronchoalveolar inflammatory cells at all time points after intratracheal challenge. Compared to both control groups, significant decreases were seen in numbers of macrophages and lymphocytes in mice treated with GKl.5. Flow cytometric analysis of bronchoalveolar lavage fluid seven days after intratracheal challenge showed that mice treated with intact GKl.5 had total absence of CD4+ T cells and had significant decreases of B cells compared to mice treated with the isotype-control antibody or no antibody (Fig.  3) . Simultaneous Histologic sections of the lungs of intratracheally challenged mice revealed a pronounced decrease in parenchymal inflammation in mice treated with GKI.5 (Fig. 4) . The mice that received no antibody as well as those treated with the irrelevant antibody developed alveolar wall congestion, extensive perivenous and periarterial cuffing with a chiefly mononuclear cell infiltrate, and adhesion of inflammatory cells to vascular endothelium. These histologic changes were identical to those previously described in this model (19) . In marked contrast, parenchymal inflammation was considerably less well developed and less uniform in mice treated with GK1.5. Many areas of lung of mice treated with GKI.5 appeared essentially normal. The histologic scoring of specific aspects ofinflammation (Fig. 5) showed that GKl.5 treatment decreased those scores which reflect parenchymal inflammation (alveolar, perivenous, and periarterial scores) and attachment of leukocytes (which are primarily mononuclear cells) to venous endothelium. Treatment with intact GKl.5 had less of an effect, however, on the attachment ofleukocytes (which are chiefly neutrophils) to arterial endothelial cells. Absence ofCD4from murine alveolar macrophages. Alveolar macrophages from mice that had not received injections of GK1.5 showed negligible CD4 staining when analyzed by flow cytometry using allophycocyanin. In normal mice, alveolar macrophages were 1.4% CD4+ (n = 9 mice, pooled lavage), whereas in primed mice 7 d after intratracheal antigen challenge, alveolar macrophages were 1.08±0.29% CD4+ (mean±SE, n = 4 mice individually assayed).
Effect oftreatment with F(ab')2 fragments ofGKI.5 on inflammatory cell recruitment to the lungs. Injection of F(ab')2 fragments of GKl.5 blocked CD4 molecules on lymphocytes ofprimed mice, as shown by absent staining with GK1.5-FITC and staining with MAR 18.5-FITC (Fig. 6) . In mice treated with F(ab')2 fragments of GKI. blood, 19.3±1.5% in spleen. Just as was seen with intact antibody, treatment with F(ab')2 fragments of GK1.5 significantly decreased recovery of total cells and of macrophages and lymphocytes by bronchoalveolar lavage (Fig. 7) . Analysis of histologic sections of mice treated with F(ab')2 fragments gave results similar to those of the intact antibody experiments (Fig. 8) . This experiment was performed on day 3 after intratracheal challenge and the resulting histologic scores were intermediate between the results of intact antibody studies performed on days 2 and 4 after intratracheal challenge (Fig. 5 ).
To determine whether treatment caused persistent effects on CD4+ T cells, in a separate experiment we stopped administration of F(ab')2 fragments of GK1.5 the day of intratracheal antigen challenge and assayed mice 4 Histologic Scores Figure 8 . Histologic scores of mice treated with F(ab')2 fragments.
Lungs were prepared for histologic section three days after intratracheal challenge of primed mice treated with F(ab')2 fragments of GKl.5 or SFR8-B6. Sections were scored blindly using the criteria listed in Table II CD4+ T cells were again detectable without GKl.5 blockade. Analysis both of bronchoalveolar lavage and of histology showed a vigorous pulmonary immune response, indistinguishable from that in the untreated group (data not shown).
Pulmonary immune response in athymic mice. Because these results suggested that functional CD4+ T cells are essential for the pulmonary immune response to sheep red blood cells, we predicted that inflammatory and immune cells would not be recruited to the lungs of athymic mice, which lack mature T cells. Results of both bronchoalveolar lavage cell yields and histologic scoring (Fig. 9) confirmed this prediction. Aside from erythrocyte-packed alveolar macrophages, lungs of athymic mice appeared essentially normal, in marked contrast to their normal littermates. lung diseases and of host defense of the lung, highlighting the critical role of the specific (i.e., antigen-driven) immune response and in particular ofCD4+ T cells, in amplifying inflammatory effector mechanisms. The end-points used in this study (analysis of cell numbers and phenotypes in bronchoalveolar lavage fluid and of histology) were chosen because they give complementary views of the inflammatory process. Analysis of bronchoalveolar lavage cells examines the entire alveolar surface in an integrated, quantitative fashion. In previous experiments in this model, we have noted excellent agreement between lymphocyte phenotypes in bronchoalveolar lavage fluid and in minced lungs following exhaustive lavage (18) . We have interpreted this agreement to indicate that lymphocytes in the alveolar space are representative ofthose in the interstitium, the major site ofthe immune response. On the other hand, histologic analysis permits a detailed assessment of the sequence of changes at specific anatomic locations. We have previously shown that these endpoints are reasonable markers for production of specific antibody-forming cells in the lung. To our knowledge, the effect ofdepleting CD4+ T cells on cellular recruitment during a pulmonary immune response has been examined only by Allen et al. (34) , who studied murine influenza. Interestingly, they found that depleting CD4+ T cells had little effect on cellular recruitment and no effect on clearance of virus in this class I MHC-restricted system. Although Mody et al. (35) demonstrated decreased survival and increased organism burden in CD4-depleted mice experimentally infected with Cryptococcus neoformans, they did not investigate the effect of treatment on cellular recruitment to the lungs.
Discussion
Our results are best interpreted in light of our previous observations in this model system. Intratracheal deposition of sheep red blood cells into a naive mouse induces a prompt primary immune response in the draining mediastinal lymph nodes, even at relatively low doses of antigen, but minimal response in the lung parenchyma, unless extremely high doses of antigen are used (16, 18, 19) . Thus, the normal lung has a tremendous capacity to clear antigen without permitting a parenchymal immune response. In contrast, the immune mouse rapidly recruits large numbers of inflammatory and immune cells to the lung parenchyma and alveolar spaces in response to intratracheal antigen (18) . The current study is part of an ongoing effort to define the cellular basis for this recruitment. One of our early hypotheses was that lymphocyte recruitment in the immune mouse results from monokines released as macrophages ingest opsonized antigen. This hypothesis predicts that ablation of CD4+ T cells would prevent maturation of B cells into specific antibody-forming cells, but would have little impact on their initial recruitment. However, the current data show that in the absence of CD4+ T factorial process that depends on display and recognition of adhesion molecules on both the leukocyte and the endothelial cell, directed migration along chemotactic gradients, and transmigration across the endothelium, basement membrane, and interstitium (12, 36, 37 (48) (49) (50) , prolonged depression of humoral immune responses (51, 52) , and delayed allograft rejection (53) . Depletion of CD4+ T cells also worsens the clinical course in some (35) but not all infectious disease models (54) (55) (56) . Improved outcome seen in CD4-depleted mice with experimental leishmaniasis has been taken as evidence for immunoregulatory subsets of CD4+ T cells which dampen the normal host response (57) . Because in vivo treatment with antibody against CD4 induces immune tolerance, it is not complicated by development ofa host response to the injected antibody, a common problem of in vivo treatment with other monoclonal antibodies (58) .
In vivo treatment with F(ab')2 fragments ofGK1.5 appears to have similar immunosuppressive effects as treatment with intact antibodies, without depleting CD4+ T cells (23) . Anti-CD4 F(ab')2 fragments are believed to be immunosuppressive in part because they inhibit the binding of CD4+ cells to antigen-presenting cells (59) . The CD4 molecule interacts with nonpolymorphic determinants of class II MHC antigens on antigen-presenting cells, functioning both as an adhesion molecule and as co-receptor which is capable, through its association with the tyrosine-protein kinase p56'k, of transducing an activation signal to the helper T cell (60, 61) . Therefore, the 1. Abbreviation used in this paper: TNF, tumor necrosis factor. effect of F(ab')2 fragments of GKl.5 on inflammatory cell recruitment in this study suggests that the generation of recruitment signals requires an interaction with antigen-presenting cells.
Two other possible actions of F(ab')2 treatment should be considered. First, it has previously been shown that cross-linking certain CD4 determinants in vitro in the absence of accessory cells inhibits subsequent activation of the T cell (62). Because they are bivalent, F(ab')2 fragments of GKl.5 might cross-link CD4 and thus render T cells unresponsive to stimulation by antigen. However, the prompt recovery of the pulmonary immune response that we observed when treatment with F(ab')2 fragments of GK1.5 was stopped argues that if such an action exists in vivo, the effect is not prolonged. Second, by blocking the CD4 molecule, F(ab')2 treatment might also impede the action of lymphocyte chemotactic factor, which uses CD4 as its receptor (63) . Lymphocyte chemotactic factor is a small molecular weight peptide, produced exclusively by CD8+ T cells, which is selectively chemoattractant for CD4+ T cells in vitro (12) . Whether CD8+ T cells are themselves critical for cellular recruitment to the lungs is currently being investigated.
A theoretic objection to our methods is that MAR 18.5 staining would not detect any CD4+ T cells which had capped their CD4 molecules in response to antibody treatment, thus evading elimination, but which somehow remained functional. However, the antibody used, GK1.5, is reported not to induce capping ofCD4 molecules (7) . Our data from the F(ab')2 experiments support this contention, since this divalent reagent should have induced capping roughly as well as intact antibody. In fact, observed numbers ofMAR 18.5 + cells in peripheral blood closely approximated the expected numbers of CD4+ T cells in normal mice. Thus, we believe that it is unlikely that GKl.5 treatment induced appreciable capping of CD4.
Although we have focused on the profound inhibitory effect of antibody against CD4 in this experimental pulmonary immune response, it is also important to note that some response did occur in GK1.5-treated mice, suggesting a redundancy in the mechanisms of inflammatory cell recruitment. Adhesion of inflammatory cells, particularly neutrophils, to pulmonary arterial endothelial cells was minimally affected and early recovery of neutrophils by bronchoalveolar lavage was not ablated. These findings are consistent with the recently described role in neutrophil adhesion ofELAM-1, an endothelial cell molecule inducible by monokines such as TNF-a and IL-1 (64) . The lack ofeffect ofCD4 depletion on recruitment of CD8+ T cells is interesting, particularly in light of the CD8+ bronchoalveolar lymphocytosis which often accompanies human immunodeficiency virus (HIV) infection (65) . Preserved recruitment ofCD8+ T cells to the lungs during CD4 depletion was also recently observed in a murine model ofinfluenza (34) . In a new model of Pneumocystis carinii pneumonia in CD4-depleted mice (66) , we have noted a striking CD8+ pulmonary lymphocytosis (67) . All of these observations indicate that CD8+ T cells do not depend on CD4+ T cells for their recruitment to the lungs.
It is unlikely that the functional changes observed in this study resulted from the effects of GK1.5 on other cell types. Murine macrophages from sites outside the lung do not express CD4 (29) (30) (31) . Additionally, we found that alveolar macrophages both of normal mice and of mice undergoing a vigorous pulmonary immune response did not express detectable CD4. Pulmonary dendritic cells, another cell type potentially important in pulmonary immune responses, do not express CD4 in either mice or humans (68) . Thus, it is probable that the effects observed in this study were due to ablation or inactivation of CD4+ T cells.
We believe that this model will be useful in further deciphering the mechanisms of cellular recruitment to the lungs during pulmonary immune responses. Our results indicate that one mechanism by which substantial reductions in the number or function of CD4+ T cells, as is seen in HIV infection, lead to impairment of pulmonary immune responses is by drastically diminishing cellular recruitment. Our results also raise the possibility that treatment with monoclonal antibodies against CD4 might be useful in patients with refractory immunologic pulmonary diseases such as sarcoidosis or idiopathic pulmonary fibrosis. In this regard, therapy with F(ab')2 fragments may be safer than therapy with intact antibody. The brief halflife of F(ab')2 fragments would make treatment more difficult, but has the advantage of rapid reversal of immunosuppression in the event of complicating opportunistic infection. Finally, it is to be hoped that understanding the mechanisms regulating cellular recruitment to non-lymphoid organs will result in therapeutic agents more practical than monoclonal antibodies. If such agents are discovered, the lung provides a particularly attractive organ for their use, because of the possibility of lungspecific delivery by aerosol.
